Dolby Laboratories (DLB) rated Neutral with price target $35 by Collins Stewart
Collins Stewart rated Neutral Dolby Laboratories (NYSE: DLB) on 11/14/2011. Previously Collins Stewart rated Buy Dolby Laboratories (NYSE: DLB) on 04/19/2011.,
when the stock price was $45.59. Since then, Dolby Laboratories has lost 30.09% as of 08/05/2011's recent price of $31.87. If you would have followed the previous Collins Stewart's recommendation on DLB, you would have lost 30.09% of your investment in 108 days.
develops and delivers products and technologies that make the entertainment experience more realistic and immersive. For nearly four decades, Dolby has been at the forefront of defining high-quality audio and surround sound in cinema, broadcast, home audio systems, cars, DVDs, headphones, games, televisions, and personal computers. Based in San Francisco with headquarters in England, the company has entertainment industry liaison offices in New York and Los Angeles, and licensing liaison offices in London, Shanghai, Beijing, Hong Kong, and Tokyo.
's research department is built around a number of sector-specialist teams. Our analysts are leaders in their area of specialisation and combine deep industry knowledge with decades of stock broking experience to produce insightful, independent sector research. Our research approach encompasses Quest™ principles and focuses on cash-driven valuation techniques. Research is a Collins Stewart
cornerstone; it is leveraged throughout the organisation.